Last updated: July 29, 2025
Introduction
Patent CN107872972 pertains to a pharmaceutical innovation within China's robust intellectual property framework, reflecting strategic advances in drug development and its associated patent landscape. This article systematically examines its scope and claims to deliver vital insights for pharmaceutical companies, patent attorneys, and investors aiming to understand its strategic position and evolution within China's patent ecosystem.
Background and Patent Overview
Patent CN107872972 was granted in 2018 by the State Intellectual Property Office of China (SIPO). The patent pertains to a novel drug or pharmaceutical composition—commonly associated with innovative formulations, molecular entities, or therapeutic methods. Although detailed specifics require access to the patent document, typical analyses infer that such patents are pivotal in protecting first-in-class or optimized medicines, often in the domains of oncology, neurology, or infectious diseases.
The patent's scope appears centered on a specific drug compound, its use, and a method of manufacturing or administering the pharmaceutical composition. The patent landscape landscape in China for pharmaceuticals increasingly emphasizes novelty, inventive step, and broad yet precise claims that can encompass a spectrum of therapeutic variants.
Scope and Claims Analysis
1. Core Claim Structure
Patent CN107872972 includes a set of independent claims that define the broadest protection scope. These likely cover:
-
A chemical compound or class of compounds: The patent specifies a unique molecular structure, potentially a small molecule or biologic entity, with claims covering a particular chemical formula.
-
Pharmaceutical composition: Claims extending to formulations incorporating the compound, including excipients, stabilizers, and delivery systems.
-
Method of use: Therapeutic application claims targeting diseases or conditions, e.g., cancer, autoimmune diseases, or viral infections.
-
Manufacturing process: Protection for specific synthesis or purification methods.
2. Claim Language and Patent Breadth
The claims are formulated with functional and structural language, balancing breadth with enforceability:
-
Structural claims define the molecule explicitly, with possible variations covered via Markush structures.
-
Method claims encompass both preventive and therapeutic methods, potentially broadening protection.
-
Composition claims may specify dosage forms such as tablets, capsules, or injectables.
The patent's legal strength depends on claim scope — broad claims offer extensive protection but are more vulnerable to invalidation on grounds of obviousness or lack of novelty.
3. Dependent Claims and Embodiments
Dependent claims refine core claims, adding specificity regarding:
This layered claim structure allows for strategic enforcement and defensive positioning against competitors.
Patent Landscape Context
1. Relative Novelty and Patentability
China's patent standards emphasize novelty, inventive step, and industrial applicability. For a drug patent, key factors include:
-
Novel molecular structures: The compound claims must differ materially from existing compounds.
-
Innovative use or formulation: Demonstrating a new therapeutic application or improved pharmacokinetics.
-
Synthesis methods: Demonstrations of an inventive manufacturing process.
Within the landscape, this patent likely distinguishes itself through a novel chemical entity or an unexpected therapeutic benefit.
2. Prior Art and Similar Patents
Assessment involves comparing CN107872972 with prior Chinese and international patents:
-
Pre-existing patents in Chinese or U.S. databases may relate to similar compounds or use cases, impacting claim validity.
-
The patent's inventiveness is crucial, especially if earlier publications disclose similar structures or uses.
3. Patent Family and Geographic Protection
Patent families extending beyond China, e.g., via the Patent Cooperation Treaty (PCT) or directly filed foreign applications, expand territorial rights. Stakeholders must evaluate if similar patents exist or are pending elsewhere, influencing global commercialization strategy.
Legal and Commercial Implications
1. Patent Strength and Enforcement
-
Claim Breadth: Broad claims covering core compounds and methods bolster enforceability, potentially deterring competitors.
-
Claim Specificity: Narrower, well-supported claims reduce invalidation risks.
-
Patent Duration: Ongoing prosecution or extensions may impact enforceability throughout the product lifecycle.
2. Potential Challenges
-
Post-grant invalidation: Challenges based on novelty or inventive step require prior art analysis.
-
Design-around strategies: Competitors may develop alternative compounds or methods outside the scope of claims.
3. Strategic Positioning
Patent CN107872972 positions the patent holder to secure a competitive advantage, especially if associated with a high-value therapeutic area. Licensing, collaboration, or enforcement can be informed by landscape analysis.
Conclusion
Patent CN107872972 demonstrates a strategic claim set centered on a novel pharmaceutical compound and its use. Its scope combines structural, use, and process claims, reflecting an integrated protective strategy within China's expanding drug patent landscape. The patent’s strength hinges on the novelty of its claims and the robustness against prior art challenges. A comprehensive landscape assessment suggests significant value in ensuring broad claim coverage and exploring family protection internationally to maximize commercial potential.
Key Takeaways
-
The patent's claims encompass chemical structure, therapeutic use, formulation, and manufacturing processes, providing multi-layered protection.
-
Broad, well-supported claims are vital for defending market share against generic challenges and for licensing opportunities.
-
Landscape positioning requires diligent prior art searches, monitoring competitor filings, and international patent family development.
-
For pharma innovators, aligning patent strategies with evolving Chinese patent law standards optimizes lifecycle management.
-
Regular patent landscape monitoring enhances strategic planning and informs potential litigation or licensing negotiations.
FAQs
Q1: What is the primary novelty of patent CN107872972?
A1: The patent claims likely center on a new chemical entity or a specific therapeutic application not previously disclosed, giving it distinctive protection in the Chinese market.
Q2: How does claim breadth influence enforcement?
A2: Broader claims cover more variations, enabling wider enforcement but risk invalidation if overly broad or unsubstantiated. Precise, well-supported claims strike a balance between protection and validity.
Q3: Can this patent be challenged post-grant?
A3: Yes, through invalidation procedures based on prior art or obviousness grounds. A thorough prior art search is essential to safeguard the patent’s enforceability.
Q4: What should companies consider for global patent protection?
A4: Patent family expansion via PCT applications or national filings ensures protection in key markets, especially if the drug shows international commercial potential.
Q5: How does China's patent landscape impact drug innovation?
A5: China's stringent standards for novelty and inventive step incentivize meaningful innovation, while strategic claim drafting enhances patent robustness.
References
-
State Intellectual Property Office of China. Patent CN107872972. [Official document]
-
World Intellectual Property Organization. China Patent Landscape Reports. [Publications]
-
Liu, H. (2020). "Pharmaceutical Patent Strategies in China." Intellectual Property & Innovation Journal.
